Trial reportContrast media & molecular imaging2020
Paola Vallejo-Armenta, Clara Santos-Cuevas, Juan Soto-Andonaegui, Rosa M Villanueva-Pérez, Jorge I González-Díaz, Francisco O García-Pérez, Angélica Arrellano-Zarate, Myrna Luna-Gutiérrez, Erika Azorín-Vega, Blanca Ocampo-García and 1 more
Trial report in Contrast media & molecular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
4 citing papers in PubMed, 12 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors at 2 institutions in 1 country.
Paola Vallejo-ArmentaDepartamento de Medicina Nuclear, Hospital de Especialidades del Centro Médico Nacional Siglo XXI, Ciudad de México 06720, Mexico.
Clara Santos-CuevasDepartamento de Materiales Radiactivos, Instituto Nacional de Investigaciones Nucleares (ININ), Ocoyoacac 52750, Estado de México, Mexico.
Juan Soto-AndonaeguiDepartamento de Medicina Nuclear, Hospital de Especialidades del Centro Médico Nacional Siglo XXI, Ciudad de México 06720, Mexico.
Rosa M Villanueva-PérezDepartamento de Medicina Nuclear, Hospital de Especialidades del Centro Médico Nacional Siglo XXI, Ciudad de México 06720, Mexico.
Jorge I González-DíazDepartamento de Medicina Nuclear, Hospital de Especialidades del Centro Médico Nacional Siglo XXI, Ciudad de México 06720, Mexico.ORCID 0000-0003-0211-2818
Francisco O García-PérezDepartamento de Medicina Nuclear, Hospital de Especialidades del Centro Médico Nacional Siglo XXI, Ciudad de México 06720, Mexico.
Angélica Arrellano-ZarateDepartamento de Medicina Nuclear, Hospital de Especialidades del Centro Médico Nacional Siglo XXI, Ciudad de México 06720, Mexico.
Myrna Luna-GutiérrezDepartamento de Materiales Radiactivos, Instituto Nacional de Investigaciones Nucleares (ININ), Ocoyoacac 52750, Estado de México, Mexico.
Erika Azorín-VegaDepartamento de Materiales Radiactivos, Instituto Nacional de Investigaciones Nucleares (ININ), Ocoyoacac 52750, Estado de México, Mexico.ORCID 0000-0002-7520-461X
Blanca Ocampo-GarcíaDepartamento de Materiales Radiactivos, Instituto Nacional de Investigaciones Nucleares (ININ), Ocoyoacac 52750, Estado de México, Mexico.ORCID 0000-0002-5831-8412
Guillermina Ferro-FloresDepartamento de Materiales Radiactivos, Instituto Nacional de Investigaciones Nucleares (ININ), Ocoyoacac 52750, Estado de México, Mexico.ORCID 0000-0003-0296-7605
Centro Medico Nacional Siglo XXI · MXInstituto Nacional de Investigaciones Nucleares · MX
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Overexpression of the chemokine-4 receptor (CXCR4) in brain tumors is associated with high cancer cell invasiveness. Recently, we reported the preclinical evaluation of
Indexed as
Proof of Concept StudyRadiometryAdultBrain NeoplasmsFemaleFollow-Up StudiesHumansMagnetic Resonance ImagingMaleNeoplasm InvasivenessReceptors, CXCR4TechnetiumTomography, Emission-Computed, Single-PhotonWhole Body ImagingReceptors, CXCR4Technetium
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.